PeptideStack
5.2kquestions
20kanswers
220users

How do I reconcile 98.2% from PeptideMeter with 99.4% from the supplier?

Asked 15 Mar 2026Modified 3 months agoViewed 3.9k times
15

The specifics, since they change the answer: 98.2% · PeptideMeter · 99.4%.

Something has gone wrong and I would like to know how badly before I decide what to do.

Nothing else in the setup changed, which is what makes this puzzling.

What is the differential here, and which test discriminates between the options?

purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

788 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
shareeditfollowflag
M1
askedmass_shift_1814k1815 Mar 2026
The placebo-arm figure is the part everyone omits. – felix_araya 5 months ago
add a comment

2 Answers

Accepted answer first, then by votes
15

Accepted answer

Worth being precise here: the honest answer is that the achievable range of plausible purity figures for a given vial is wider than most people expect.

Sample solvent strength affects peak shape — if you inject in strong solvent on a gradient starting in weak solvent, the solvent peak can distort your main peak or create a false shoulder.

On the detail: integration of the shoulder — whether you use perpendicular drop or tangent skim — determines what area gets assigned to the main peak versus the impurity table.

Inter-laboratory studies on identical peptide material routinely find half-a-per-cent to a full-per-cent spreads in reported purity on the same sample.

Worth noting that method standardisation is poor in the research-grade space compared to pharmaceutical work, so identical-looking methods can produce different results.

If you are ranking vendors, specify a method and have all samples tested at the same place.

edited 19 Apr 2026 by lipid_panel_q — fixed an arithmetic slip in the third paragraph

shareimprove this answerflag
LQ
answered · acceptedlipid_panel_q44k13818 Apr 2026
5Thank you — the worked example is what makes this usable. – tyndall_haze 4 months ago
6Related: the same reasoning applies to the counter-ion question. – tare_weight 6 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
9

The relevant detail is that read the chromatogram before you read the number, because the number without the trace is not a measurement, it is a claim.

Gradient slope controls resolution, and gentler slopes resolve co-eluting impurities into separate peaks — so the better method reports the worse purity number.

Mass on column affects detector linearity and peak overlap — overloading broadens peaks and hides neighbours, while underloading improves resolution but loses sensitivity.

The Arrhenius relationship for peptide degradation is the basis of accelerated stability testing and also governs how quickly methods drift with temperature.

I would be careful about over-reading a single measurement — treat it as a data point, not as ground truth.

Compare purity within a single laboratory on the same method, never across laboratories.

shareimprove this answerflag
HP
answeredh_pergande86k25830 Apr 2026
The timing signature is the useful part. Everything else is confounded. – deamidation_watch 5 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.